Real-world efficacy of treatment with benralizumab, dupilumab, mepolizumab and reslizumab for severe asthma: A systematic review and meta-analysis

Charles, D; Shanley, J; Temple, SN; Rattu, A; Khaleva, E; Roberts, G

Roberts, G (通讯作者),Southampton NHS Fdn Trust, Univ Hosp, Univ Child Hlth MP803, Paediat Allergy & Resp Med, Tremona Rd, Southampton SO16 6YD, Hants, England.

CLINICAL AND EXPERIMENTAL ALLERGY, 2022; 52 (5): 616

Abstract

Background Severe asthma is a major cause of morbidity. Some patients may benefit from biological therapies. Most evaluations of these treatments are ......

Full Text Link